Nexo Therapeutics, Inc.

Amendment
CIK: 0001955319·Biotechnology·DELAWARE·Filed: Sep 13, 2024
Total Offering

$60,000,000

Amount Sold

$45,000,000

Investors

6

First Sale

Nov 15, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Andrew Phillips
Related Person
Michael Kim
Related Person
Ali Behbahani
Related Person
Carlo Rizzuto
Related Person

Company

Nexo Therapeutics, Inc.

11757 W. KEN CARYL AVENUE

LITTLETON, CO, 80127-3719

303-868-6790

SEC Filing

0001955319-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Nexo Therapeutics, Inc. Form D Filing — $60,000,000 | FilingFlow